← All tickers

Is MDLN Worth Buying in 2026?

Medline Inc. Class A common stock

STOCK SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Updated 2026-06-07

Here’s whether Medline Inc. Class A common stock (MDLN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.

🟡
Caution

Positives: RSI 39 — healthy momentum range. Concerns: below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-3.18% over 10 days); 3-month momentum negative (-22.6%); rising volume on a downtrend (distribution, 1.63x avg). Currently 33.9% off its 52-week high. Score: -2/7.

Ready to act on this? 📈 Trade on Webull

MDLN is trading below its 200-day MA (—) — a key warning sign the longer-term trend is under pressure. An RSI of 39.4 sits in the neutral zone — momentum is neither stretched nor exhausted. With ~6 months of trading history, the return since first available bar is -18.0%. The current 33.9% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 6 months ago → $8,198 today

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✗Above 50-day MA ($41.61)
✗Above 13-day MA ($35.76)
✓RSI(7) neutral zone (30–70) — currently 33.4
✗Positive return (-22.6%)
!Within 10% of period high (−31.6%)
Period Range $33.61
$32.82 $49.14
RSI (7) 33.4
0 · OversoldOverbought · 100

Key Metrics

Price$33.61
Period Return-22.6%
Period High$49.14
Period Low$32.82
Drawdown−31.6%
MA-13$35.76
MA-50$41.61
RSI (7)33.4
Avg Volume (30d)11.3M
vs. SPYtrailed by 31.3%

Trade MDLN

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers